Reference | 1: Dibué-Adjei M, Kamp MA, Alpdogan S, Tevoufouet EE, Neiss WF, Hescheler J,
Schneider T. Cav2.3 (R-Type) Calcium Channels are Critical for Mediating
Anticonvulsive and Neuroprotective Properties of Lamotrigine In Vivo. Cell
Physiol Biochem. 2017 Nov 24;44(3):935-947. doi: 10.1159/000485361. [Epub ahead
of print] PubMed PMID: 29176325.
<br>
2: Linder C, Hansson A, Sadek S, Gustafsson LL, Pohanka A. Carbamazepine,
lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid
chromatography tandem mass spectrometry; method development and validation. J
Chromatogr B Analyt Technol Biomed Life Sci. 2017 Nov 4;1072:116-122. doi:
10.1016/j.jchromb.2017.11.005. [Epub ahead of print] PubMed PMID: 29149735.
<br>
3: Sidhu HS, Srinivasa R, Sadhotra A. Evaluate the effects of antiepileptic drugs
on reproductive endocrine system in newly diagnosed female epileptic patients
receiving either Valproate or Lamotrigine monotherapy: A prospective study.
Epilepsy Res. 2017 Oct 28;139:20-27. doi: 10.1016/j.eplepsyres.2017.10.016. [Epub
ahead of print] PubMed PMID: 29144993.
<br>
4: Narenji Sani R, Keramati K, Saberi N, Moezifar M, Mahdavi A. Effect of
zonisamide on refractory epilepsy during pregnancy in lamotrigine resistant
kindled rats. Neurosci Lett. 2017 Nov 11;664:91-97. doi:
10.1016/j.neulet.2017.11.020. [Epub ahead of print] PubMed PMID: 29133176.
<br>
5: Premoli I, Costantini A, Rivolta D, Biondi A, Richardson MP. The Effect of
Lamotrigine and Levetiracetam on TMS-Evoked EEG Responses Depends on Stimulation
Intensity. Front Neurosci. 2017 Oct 20;11:585. doi: 10.3389/fnins.2017.00585.
eCollection 2017. PubMed PMID: 29104528; PubMed Central PMCID: PMC5655014.
<br>
6: Kanda J, Izumo N, Kobayashi Y, Onodera K, Shimakura T, Yamamoto N, E Takahashi
H, Wakabayashi H. Effects of the antiepileptic drugs topiramate and lamotrigine
on bone metabolism in rats. Biomed Res. 2017;38(5):297-305. doi:
10.2220/biomedres.38.297. PubMed PMID: 29070779.
<br>
7: Andersen G, Hedermann G, Witting N, Duno M, Andersen H, Vissing J. The
antimyotonic effect of lamotrigine in non-dystrophic myotonias: a double-blind
randomized study. Brain. 2017 Sep 1;140(9):2295-2305. doi: 10.1093/brain/awx192.
PubMed PMID: 29050397.
<br>
8: Cohen-Israel M, Berger I, Martonovich EY, Klinger G, Stahl B, Linder N. Short-
and long-term complications of in utero exposure to lamotrigine. Br J Clin
Pharmacol. 2017 Oct 18. doi: 10.1111/bcp.13437. [Epub ahead of print] PubMed
PMID: 29044597.
<br>
9: Trunko ME, Schwartz TA, Berner LA, Cusack A, Nakamura T, Bailer UF, Chen JY,
Kaye WH. A pilot open series of lamotrigine in DBT-treated eating disorders
characterized by significant affective dysregulation and poor impulse control.
Borderline Personal Disord Emot Dysregul. 2017 Oct 8;4:21. doi:
10.1186/s40479-017-0072-6. eCollection 2017. PubMed PMID: 29043085; PubMed
Central PMCID: PMC5632524.
<br>
10: Kaufman KR, Coluccio M, Sivaraaman K, Campeas M. Lamotrigine-induced sexual
dysfunction and non-adherence: case analysis with literature review. BJPsych
Open. 2017 Oct 4;3(5):249-253. doi: 10.1192/bjpo.bp.117.005538. eCollection 2017
Sep. PubMed PMID: 29034101; PubMed Central PMCID: PMC5627137.
|